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Abstract
Streptococcus pneumoniae pilus islet-1 (PI-1)-encoded pilus enhances in vitro adhesion to the respiratory epithelium and may contribute to
pneumococcal nasopharyngeal colonization and transmission. The pilus subunits are regarded as potential protein vaccine candidates. In this
study, we sought to determine PI-1 prevalence in carried pneumococcal isolates and explore its relationship with transmissibility or car-
riage duration. We studied 896 pneumococcal isolates collected during a longitudinal carriage study that included monthly nasopharyngeal
swabbing of 234 infants and their mothers between the ages of 1 and 24 months. These were cultured according to the WHO pneumo-
coccal carriage detection protocol. PI-1 PCR and genotyping by multilocus sequence typing were performed on isolates chosen according
to speciﬁc carriage and transmission deﬁnitions. Overall, 35.2% of the isolates were PI-1-positive, but PI-1 presence was restricted to ten
of the 34 serotypes studied and was most frequently associated with serotypes 19F and 23F; 47.5% of transmitted and 43.3% of non-trans-
mitted isolates were PI-1-positive (OR 1.2; 95% CI 0.8–1.7; p 0.4). The duration of ﬁrst-ever infant pneumococcal carriage was signiﬁcantly
longer with PI-1-positive organisms, but this difference was not signiﬁcant at the individual serotype level. In conclusion, PI-1 is commonly
found in pneumococcal carriage isolates, but does not appear to be associated with pneumococcal transmissibility or carriage duration.
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Introduction
Streptococcus pneumoniae is a signiﬁcant global pathogen [1].
Additionally, pneumococcus is a nasopharyngeal commensal,
and infants are frequently colonized [2,3]. Various cell sur-
face components, including pneumococcal surface adhesin A,
choline-binding protein A, pneumococcal serine-rich repeat
protein, and pneumococcal adherence-virulence factor A,
have been shown to contribute to nasopharyngeal adherence
and colonization, but their mechanisms of action remain
incompletely understood [3–7]. The RrgA subunit of the sur-
face exposed pilus-1 ﬁlamentous structure also enhances
pneumococcal adherence to respiratory epithelial cells in vitro
[8,9]. Pneumococcal pilus-1 is encoded by the pilus islet-1
(PI-1; rlrA islet), and is composed of three subunits: RrgA,
RrgB, and RrgC [9–11]. As immunization with pilus antigens
is protective against lethal intraperitoneal challenge in a
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mouse model, pilus subunits are regarded as potential candi-
dates for inclusion in a protein-based pneumococcal vaccine
[12]. However, PI-1 presence is not universal: studies of pre-
dominantly invasive pneumococci have found that PI-1 is
present in isolates from a limited number of serotypes
(particularly those included in the pneumococcal seven-valent
conjugate vaccine (PCV7)) and that its presence correlates
with genotype by multilocus sequence typing (MLST) [13–
18]. Given the prevalence of asymptomatic colonization, and
the fact that the serotype/genotype structure of invasive
pneumococci is not stable [19], further work to describe the
prevalence and function of pilus-1 in pneumococcal carriage
strains is warranted.
In this study, our aims were to: (i) determine PI-1 preva-
lence in pneumococcal carriage isolates from infants and
their mothers; (ii) determine which PI-1-positive clones were
associated with carriage in the study region; and (iii) explore
the possible functions of the pilus in vivo, and in particular
evaluate whether PI-1 presence had an effect on pneumococ-
cal transmission or carriage duration.
Materials and Methods
Pneumococcal isolates
The isolates characterized in this work were collected from
2007 to 2010, during a longitudinal carriage and pneumonia
study of 965 infants at Maela refugee camp, Thailand. Maela
was established in 1984, and c. 40 000 Burmese refugees,
predominantly of Karen ethnicity, live in a 4-km2 area. Pneu-
mococcal vaccines are not available in the camp. Nested
within the study was a subcohort of 234 mother–infant pairs
who were studied in more detail: between 1 and 24 months
of age, these infants had a nasopharyngeal swab (NPS) and
blood taken at monthly surveillance visits, and their mothers
had an NPS taken at the same time. NPSs were processed
according to the WHO pneumococcal colonization protocol,
as previously described [20,21]. All morphologically distinct
pneumococcal isolates from each swab culture were sero-
typed by latex agglutination [22]. Non-typeable (NT) isolates,
either morphologically typical pneumococcal colonies (proba-
bly encapsulated organisms) or rough colonies (probably non-
encapsulated organisms) that were non-reactive with typing
antisera, were conﬁrmed by bile solubility and absent capsular
swelling with Omniserum (Statens Serum Institute, Hillerod,
Denmark). Serotype 6C was identiﬁed by PCR [23].
Mother and infant pneumococcal carriage patterns for the
ﬁrst 12 months of follow-up were reviewed, and isolates
were chosen for further analysis according to the deﬁnitions
described below.
Deﬁnition of transmission and carriage
Transmission of a pneumococcus was deﬁned as the pres-
ence of an identical pneumococcal serotype and MLST geno-
type in both mother and infant at the same visit
(‘concordant transmission’) or when the pneumococcus was
isolated from the mother and the infant during a ‘transmissi-
bility episode’ but not at the same visit (‘discordant transmis-
sion’). A non-transmitted pneumococcus was a carried
serotype that never appeared in the other member of the
mother–infant pair during the transmissibility episode as
deﬁned below (Fig. S1). Transmissibility episodes were identi-
ﬁed by carriage within a mother–infant pair when there was
the same pneumococcal serotype cultured from two or
more NPSs (from mother and/or infant), separated by two
or fewer NPSs negative for that serotype. For serotypes 1
and 5, which are known to be carried for very short dura-
tions, a single positive NPS could deﬁne non-transmission.
For the determination of carriage duration in infants, a
pneumococcal acquisition was deﬁned as midpoint between
the last negative swab and the ﬁrst positive swab for a given
serotype. Termination of the carriage episode was similarly
deﬁned as the midpoint between the ﬁrst of two consecutive
negative swabs and the last positive swab for the serotype.
PI-1 detection
PI-1 presence was determined as previously described [14].
Brieﬂy, PCRs were performed directly from bacteria, with the
primers listed in Table S1. Primers were designed on con-
served regions on the boundaries of PI-1 (459for and 470rev)
and within PI-1 (P01rev, P11for, P08for, and P08rev).
MLST
MLST was performed as previously described [24]. Brieﬂy,
PCR ampliﬁcations were performed directly from the bacte-
ria with the standard primer pairs. Sequences were obtained
on both strands with an ABI 3730xl DNA Analyzer (Life
Technologies Corporation, Carlsbad, CA, USA). Sequence
type (ST) was determined by use of the MLST website
(http://spneumoniae.mlst.net). eBURST (http://spneumoniae.
mlst.net/eburst/) was run with default settings on the entire
MLST database, and each ST was assigned to a clonal com-
plex (CC) [25]. CCs were named in accordance with the ST
number of the founder predicted by eBURST.
Statistical analysis
Statistical analyses were carried out with STATA 10.1 (Stata-
Corp, College Station, TX, USA). The chi-squared test, Fish-
er’s exact test and ORs were used to compare proportions.
Carriage duration was estimated by survival analysis methods,
with the log-rank test being used to compare groups [2].
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Study ethics
Ethical approval for the carriage study was granted by Mah-
idol University, Thailand and Oxford University, UK.
Results
Pneumococcal isolates and PI-1 prevalence
In the ﬁrst 12 months of follow-up, 4921 surveillance NPS
were collected from the 234 mother–infant pairs (84.7% of
expected). In total, 2497 isolates were cultured, and 896
(35.9%) of these were included in the current work. All iso-
lates meeting the criteria described below were included,
resulting in 34 serotypes being represented in the isolate
selection. These serotypes accounted for 90.1% (2251/2497)
of isolates in the entire cohort isolate collection.
We successfully determined the PI-1 status of 887/896
(98.9%) isolates: 35.2% (312/887) were positive. PI-1-positive
isolates were restricted to ten serotypes: 4, 6A, 6B, 9, 14,
19F, 19A, 23F, 33C, and NT (Fig. 1).
PI-1 and transmission
To determine whether PI-1 presence had an effect on pneu-
mococcal transmission within the mother–infant pairs, a
panel of isolates was selected and analysed by both PI-1 PCR
and MLST (to deﬁne genotype). We elected to study sero-
types contained in, or related to, current conjugate vaccines
(PCV13 + 6C), as well as NT isolates, which were overrep-
resented in our population (the commonest pneumococcal
‘type’ identiﬁed from mother swabs, and the third common-
est in infants). In the ﬁrst year of follow-up, these serotypes
accounted for 69.6% and 59.8% of isolates carried by infants
and mothers, respectively. In the case of a potentially trans-
mitted pneumococcal serotype, i.e. isolates carried by both
mother and infant at the same visit, or at sequential visits,
single isolates from both mother and infant were selected
for study. For non-transmitted isolates, i.e. isolates carried
by only the mother or infant, a single isolate was studied.
Additionally, we analysed every isolate from carriage epi-
sodes of all serotypes in eight mother–infant pairs to deter-
mine the clonality of pneumococcal carriage.
Of the 489 isolates selected for the primary analysis, PI-1
PCR was uninterpretable in six, resulting in 483 analysable
isolates. Overall, 219/483 (45.3%) of these were PI-1 posi-
tive. PI-1 was found in NT isolates and in 6/14 serotypes
studied, all of which, apart from one 19A isolate, were PCV7
serotypes (Table 1). PI-1 was found most frequently in 19F
(91%) and 23F (77%) isolates, although these serotypes,
according to the MLST and eBURST analyses, were domi-
nated by a single CC each (19F, CC271; 23F, CC802). Over-
all, PI-1-positive isolates were members of a restricted group
of CCs (Fig. 2).
With serotyping of a representative isolate alone, 253/483
(52.4%) isolates would have been classiﬁed as transmitted
FIG. 1. Pilus islet-1 (PI-1) presence by serotype in 887 carried pneumococcal isolates (includes all commonly carried serotypes).
TABLE 1. Pneumococcal serotype distribution and isolate
transmission category in mother–infant pairs (pneumococ-
cal 13-valent conjugate vaccine serotypes plus 6C and non-
typeable (NT))
Serotype Total, N Transmitteda, N
(% within serotype)
PI-1 present, N
(% within serotype)
1 12 4 (33.3) 0 (0.00)
3 11 4 (36.4) 0 (0.00)
4 4 2 (50.0) 0 (0.00)
5 10 2 (20.0) 0 (0.00)
6A 16 6 (37.5) 0 (0.00)
6B 54 27 (50.0) 29 (53.7)
6C 15 4 (26.7) 0 (0.00)
7F 5 2 (40.0) 0 (0.00)
9V 8 4 (50.0) 5 (62.5)
14 46 28 (60.9) 15 (32.6)
18C 7 4 (57.1) 0 (0.00)
19F 89 50 (56.2) 81 (91.0)
19A 14 4 (28.6) 1 (7.1)
23F 82 38 (46.3) 63 (76.8)
NT 110 57 (51.8) 25 (22.7)
Total 483 236 (48.9) 219 (45.3)
PI-1, pilus islet-1.
aConcordant and discordant transmission combined.
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(153 concordant; 100 discordant) and 230/483 (47.6%) as
non-transmitted. With a combination of MLST and serotype,
nine concordant and eight discordant ‘transmitted’ isolates
(17/483; 3.5%) were reclassiﬁed as non-transmitted, resulting
in ﬁnal totals of 236/483 (48.9%) transmitted and 247/483
(51.1%) non-transmitted isolates. PI-1 presence was not cor-
related with transmission: 47.5% (112/236) of transmitted and
43.3% (107/247) of non-transmitted isolates were PI-1 posi-
tive, with an OR of 1.2 (95% CI 0.8–1.7; p 0.4), and no signiﬁ-
cant differences were seen at the individual serotype level.
We analysed an additional 91 isolates, from seven
mother–infant pairs and one mother–twin infant unit, to con-
ﬁrm that sequential isolates of the same serotype in an indi-
vidual, and isolates of the same serotype in a mother–infant
pair, were indeed identical. In all mother–infant pairs, each
serotype carried was represented by a single ST per car-
riage/transmission episode, with three exceptions (Table S2).
PI-1 and ﬁrst pneumococcal carriage episode duration in
infants
To analyse the correlation between PI-1 presence and the
duration of infant carriage, we determined the PI-1 status of
316 isolates from the ﬁrst carriage episodes of all common
serotypes (deﬁned as serotypes with at least ten carriage epi-
sodes). These episodes included ﬁrst episodes of carriage of
each serotype, not only an infant’s ﬁrst ever pneumococcal
carriage episode. We inferred the PI-1 status for the entire
carriage episode from the PI-1 PCR result of a single isolate.
Given the well-described association of shorter carriage in
individuals with prior pneumococcal exposure, we subse-
quently focused our analysis only on ﬁrst-ever episodes of
carriage (i.e. one per infant) [2]. From the 316 carriage epi-
sodes selected, we identiﬁed 216 analysable ﬁrst-ever car-
riage episodes: PI-1 PCR data were available for at least one
isolate in 180 of these (90 pneumococcal 13-valent conjugate
vaccine serotypes, 58 non-vaccine serotypes, and 32 NT
pneumococci). Median and mean durations of the ﬁrst
pneumococcal carriage episode were 63 days (95% CI 61–
91) and 105 days (95% CI 91–119), respectively, but varied
considerably by serotype (Table 2). On comparison of the
180 carriage episodes where PI-1 PCR results were available,
PI-1-positive carriage episodes (51/180; 28.3%) were signiﬁ-
cantly longer than those associated with a PI-1-negative
organism (median 152 days (95% CI 93–213) vs. 61 days
(95% CI 57–90); mean 177 days (95% CI 137–218) vs.
84 days (95% CI 72–97); p <0.0001). However, the analysis
of carriage duration was confounded by serotype. In our
study, serotypes 19F and 23F had the longest duration of
carriage, and were both predominantly PI-1-positive. To
analyse the relative contributions of serotype and PI-1 to
carriage duration, we ﬁtted a Cox regression model and
found that, on stratiﬁcation of carriage by serotype, PI-1
presence was not associated with a signiﬁcant change in
carriage duration (hazard ratio 0.7 (95% CI 0.4–1.2; p 0.2)).
Discussion
This study is the largest investigation of the prevalence and
possible function of the PI-1-encoded pilus in carriage iso-
lates of S. pneumoniae. It also provides pneumococcal strain
data from Southeast Asia, a densely populated region that is
under-represented in the pneumococcal carriage and disease
FIG. 2. Pilus islet-1 (PI-1) presence by clonal complex in 483 carried pneumococcal isolates (pneumococcal 13-valent conjugate vaccine sero-
types plus 6C and non-typeable (NT) only).
TABLE 2. First pneumococcal carriage episode duration (six
commonest serotypes)
Serotype
Number
of episodes
Median carriage
duration (days)
(95% CI)
Mean carriage
duration (days)
(95% CI)
6B 13 121 (90–153) 119 (93–145)
14 8 62 (30–151) 86 (45–128)
19F 21 213 (63–243) 231 (154–308)
23F 21 184 (62–277) 176 (124–229)
35F 9 121 (30–180) 124 (66–182)
NT 33 31 (31–61) 72 (44–99)
NT, non-typeable.
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epidemiology literature. As serotypes are commonly used as
the basis for deﬁning transmission, we were interested in the
frequency with which a molecular analysis may confound the
analysis of transmission. By genotyping, discrepancies were
discovered in only 3.5% of transmission events classiﬁed by
serotype. We also demonstrated that pneumococci of the
same serotype are predominantly clonal within a discrete
carriage episode. We therefore concluded that serotype can
be used to deﬁne transmission events and carriage episodes
with relatively high conﬁdence, but that the inclusion of
genotyping is vital to ensure complete accuracy.
Because of the selection criteria for the isolates included in
the study, we cannot describe the overall pilus prevalence for
the population. However, in the 887 carriage isolates analysed,
the pilus prevalence was 35.2%. Among the 34 serotypes anal-
ysed, we found that PI-1 was present only in NT isolates and
nine other serotypes: 65% of PCV7 isolates were PI-1-positive,
as compared with 9% of non-vaccine serotypes. Interestingly,
Basset et al., examining nasopharyngeal and invasive pneumo-
coccal isolates from the American Indian collection, also found
that PCV7 strains were signiﬁcantly more likely to be PI-1-
positive than non-vaccine serotypes, but that the overall pro-
portion of PI-1-positive isolates was slightly lower [13]. They,
along with other authors, demonstrated that PI-1-positive
strains were contained within a small number of CCs [14–16].
Indeed, in the current study, we demonstrated that PI-1-posi-
tive isolates were clustered predominantly within four domi-
nant CCs (CC15, CC271, CC315, and CC802). The strong
association between serotype/CC and pilus presence, along
with strain selection criteria, and the different regional distri-
bution of the clones, may explain the variability in PI-1 preva-
lence between different studies.
We did not demonstrate a pilus-attributable effect on
pneumococcal transmissibility. However, there are limitations
to our study that may be important confounders for this
analysis. The carriage study was carried out in a densely pop-
ulated refugee camp where 13% of the population are
<5 years old, and there is likely to be frequent transmission
of nasopharyngeal organisms both within families and
between members of the community. Despite the use of a
combination of serotype and ST to increase the accuracy of
our transmissibility categories, we cannot exclude the possi-
bility that ‘non-transmitted’ strains were effectively transmit-
ted between mother or infant and others but not detected
by us. Several studies have documented the clustering of
pneumococcal serotypes and genotypes within families, which
highlights the difﬁculty of assigning a deﬁnitive ‘non-transmit-
ted’ label to isolates collected from an incomplete household
group [26,27]. However, we focused on mother–infant trans-
mission, because we felt that the absence of a strain in one
member of this pair would be the best marker for relative
non-transmissibility in the early months of life. In addition,
we included both concordant and discordant time-point
pneumococcal serotype/ST identiﬁcations in the mother–
infant pair as ‘transmitted’, as long as they occurred no more
than 2 months apart. However, the study sampling frequency
may have been too low to demonstrate transmission of ser-
otypes carried for very short durations. Also, in the pres-
ence of multiple serotype carriage, a common occurrence in
infancy and one that is underestimated by standard culture
protocols [21], a particular serotype may become undetect-
able for a period of time before re-emerging as the dominant
serotype, and this may result in incorrect categorization
regarding transmissibility.
Although, in the crude analysis, PI-1 presence was associ-
ated with longer ﬁrst pneumococcal carriage episodes in
infants, we could ﬁnd no signiﬁcant association between car-
riage duration and PI-1 at the individual serotype level. This
is likely to be the result of the low numbers of carriage epi-
sodes of individual serotypes (resulting in wide CIs around
the carriage duration estimates) and the restricted number
of clones within each serotype. We could have increased the
number of carriage episodes included in our analysis by look-
ing at all carriage episodes of each serotype rather than
restricting our investigation to each infant’s ﬁrst-ever car-
riage episodes, but this would have introduced other con-
founding factors, such as the impact of previous carriage and
immune factors on subsequent carriage episode duration.
Therefore, it is possible that, as a result the study sample
size, a small effect of pilus on either transmission or carriage
duration may have been missed.
In conclusion, we found that Southeast Asian pneumococ-
cal carriage isolates had a similar pilus prevalence to to that
in previously described strain collections, which is helpful in
the ongoing assessment of likely global coverage of a pilus
subunit-containing vaccine. Despite its known role in pneu-
mococcal attachment, we could not determine a clear impact
of PI-1 presence on transmissibility or carriage duration.
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